ROSE PHARMA A/S: Financial statements 2016
CVR: 27174965
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ROSE PHARMA A/S (CVR 27174965) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -35,218 and a net result of DKK -51,821 compared with DKK -186,905 the year before. Equity in the 2016 report amounted to DKK 979,327. The solvency ratio was 69.8%.
- Gross Profit
- DKK -35,218
- Profit/Loss
- DKK -51,821
- Equity
- DKK 979,327
- Total Assets
- DKK 1,402,146
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -35 t. | -52 t. | 979 t. | - |
| 2015 | - | -171 t. | -187 t. | 1 mio. | - |
| 2014 | - | 263 t. | 250 t. | 1.2 mio. | - |
| 2013 | - | -130 t. | -134 t. | 968 t. | - |
| 2012 | - | -335 t. | -335 t. | 1.1 mio. | - |
Official annual report
Find more companies like ROSE PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ROSE PHARMA A/S has published its annual report for 2015. Gross profit came to DKK -170,730, and the net result was DKK -186,905.
About ROSE PHARMA A/S
ROSE PHARMA A/S was a Danish company of the type Aktieselskab based in Roskilde, founded in 2003. The company has been dissolved on 23 April 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2007). In 2016, the company reported a gross profit of DKK -35,218 and a net result of DKK -51,821 compared with DKK -186,905 the year before. Equity in the 2016 report amounted to DKK 979,327.